EUVIMEDEUVIMED entdecken
Crossref

Phospholipid‐Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy

Riku Kawasaki iD, Hidetoshi Hirano, Keita Yamana, Ayano Oshige, Kotaro Nishimura, Nanami Kono, Yu Sanada, Kaori Bando, Anri Tabata, Naoki Yasukawa, Hideki Azuma, Takushi Takata und 7 weitere

ChemBioChem · 2023

DOI: 10.1002/cbic.202300186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2023. Verfasst von Riku Kawasaki und 18 weiteren Autor:innen. Beteiligte Einrichtung: Program of Applied Chemistry, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-4-1 Kagamiyama, 739-8527, Higashi-Hiroshim…. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Minimally invasive boron neutron capture therapy (BNCT) is an elegant approach for cancer treatment. The highly selective and efficient deliverability of boron agents to cancer cells is the key to maximizing the therapeutic benefits of BNCT. In addition, enhancement of the frequencies to achieve boron neutron capture reaction is also significant in improving therapeutic efficacy by providing a highly concentrated boron agent in each boron nanoparticle. As the density of the thermal neutron beam remains low, it is unable to induce high‐efficiency cell destruction. Herein, we report phospholipid‐coated boronic oxide nanoparticles as agents for BNCT that can provide a highly concentrated boron atom in each nanoparticle. The current system exhibited in vitro BNCT activity seven times higher than that of commercial boron agents. Furthermore, the system could penetrate cancer spheroids deeply, efficiently suppressing thermal neutron irradiation‐induced growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyNanoparticlesBoronPhospholipidsBoron CompoundsOxides

Stichwörter der Autor:innen

boron neutron capture therapydrug delivery systemslipid nanoparticlesorganic-inorganic hybrid nanomaterials

Substanzen

BoronPhospholipidsboron oxideBoron CompoundsOxides

Autor:innen und Institutionen

  • Program of Applied Chemistry, Graduate School of Advanced Science and Engineering, Hiroshima University, 1-4-1 Kagamiyama, 739-8527, Higashi-Hiroshima, Japan.
  • Institute for Integrated Radiation and Nuclear Science, Kyoto University, Asashiro-Nishi, Kumatori-cho, 590-0494, Sennan-gun, Osaka, Japan.
  • Department of Chemistry and Bioengineering Graduate School of Engineering, Osaka Metropolitan University, 3-3-138 Sugimoto, Sumiyoshi-ku, 558-8585, Osaka city, Japan.

ORCID-Profile: Riku Kawasaki

Zitieren

APA

Kawasaki, R., Hirano, H., Yamana, K., Oshige, A., Nishimura, K., Kono, N., Sanada, Y., Bando, K., Tabata, A., Yasukawa, N., Azuma, H., Takata, T., Sakurai, Y., Tanaka, H., Suzuki, M., Tarutani, N., Katagiri, K., Nagasaki, T., & Ikeda, A. (2023). Phospholipid‐Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy. ChemBioChem. https://doi.org/10.1002/cbic.202300186

Vancouver

Kawasaki R, Hirano H, Yamana K, Oshige A, Nishimura K, Kono N, et al. Phospholipid‐Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy. ChemBioChem. 2023. doi:10.1002/cbic.202300186

BibTeX
@article{Kawasaki2023,
  author = {Kawasaki, Riku and Hirano, Hidetoshi and Yamana, Keita and Oshige, Ayano and Nishimura, Kotaro and Kono, Nanami and Sanada, Yu and Bando, Kaori and Tabata, Anri and Yasukawa, Naoki and Azuma, Hideki and Takata, Takushi and Sakurai, Yoshinori and Tanaka, Hiroki and Suzuki, Minoru and Tarutani, Naoki and Katagiri, Kiyofumi and Nagasaki, Takeshi and Ikeda, Atsushi},
  title = {Phospholipid‐Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy},
  journal = {ChemBioChem},
  year = {2023},
  doi = {10.1002/cbic.202300186}
}
Kostenlos starten →